A team led by Weill Cornell Medicine and University of Miami’s Miller School of Medicine investigators has been awarded a five-year, $4 million grant from the National Institute on Drug Abuse (NIDA) for health economics research.
Fear of COVID-19 and changes to healthcare delivery during the pandemic may be causing people with substance use disorders to avoid seeking any type of care and thus less likely to get treatment for addiction.
Daily medication for treating opioid use disorder is more cost-effective compared with monthly injections, according to a study by Weill Cornell Medicine researchers.
